PATHFAST™ NT-proBNP (N-terminal-pro B type natriuretic peptide): A multicenter evaluation of a new point-of-care assay

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 7, 2010, Pages 1029-1034

  Zaninotto, Martina ^a   Mion, Monica Maria ^a   Di Serio, Francesca ^b   Caputo, Marco ^c   Ottomano, Cosimo ^d   Plebani, Mario ^a,e  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b POLICLINICO   (Italy)

^c Bussolengo Hospital   (Italy)

^d Bergamo Hospital   (Italy)

^e Leonardo Foundation   (Italy)

Author keywords

amino terminal fragment of brain natriuretic peptide (BNP) pro hormone (NT proBNP); cardiac natriuretic peptides; heart failure (HF); point of care testing (POCT)

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; EDETIC ACID; HEPARIN; LITHIUM; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHEMOLUMINESCENCE; CLINICAL COMPETENCE; CLINICAL EVALUATION; DYSPNEA; ENZYME IMMUNOASSAY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; POINT OF CARE TESTING; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; AGE; BLOOD; CHEMISTRY; CLINICAL TRIAL; EVALUATION; HOSPITAL INFORMATION SYSTEM; MIDDLE AGED; MULTICENTER STUDY; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; DYSPNEA; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POINT-OF-CARE SYSTEMS; SEX FACTORS; TRIGLYCERIDES;

EID: 77954228669     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.222     Document Type: Article

References (17)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-2442
2. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-385
3. Collins S, Lindsell CJ, Storrow AB, Abraham WT. Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med 2006;47:13-18
4. Wilson Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clin Biochem 2008;41:210-221
5. Apple FS, Wu AH, Jaffe AS, Panteghini M, Christenson RH. National Academy of Clinical Biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biomarkers of heart failure. Clin Biochem 2008;41:222-226
6. Kurihara T, Yanagida A, Yokoi H, Koyata A, Matsuya T, Ogawa J, et al. Evaluation of cardiac assays on a bench-top chemiluminescent enzyme immunoassay analyzer, Pathfast. Anal Biochem 2008;375:144-146
7. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS guideline EP5-A. Wayne, PA: NCCLS, 1999.
8. National Committee for Clinical Laboratory Standards. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; proposed guideline. NCCLS guideline EP6-P. Wayne, PA: NCCLS, 1986.
9. Di Serio F, Ruggieri V, Varraso L, De Sario R, Mastrorilli A, Pansini N. Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010. Clin Chem Lab Med 2005;43:1263-1273
10. Altinier S, Mion M, Cappelletti A, Zaninotto M, Plebani M. Rapid measurement of cardiac markers on Stratus CS. Clin Chem 2000;46:991-993
11. National Committee for Clinical Laboratory Standards. Interference testing in clinical chemistry: proposed guideline. NCCLS guideline EP7-P. Wayne, PA: NCCLS, 1986.
12. Clark TJ, McPherson PH, Buechler KF. The Triage cardiac panel: cardiac markers for the Triage system. Point Care 2002;1: 42-46
13. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. Eur Heart J 2006;27:330-337
14. Apple FS, Panteghini M, Ravkilde J, Mair J, Wu AH, Tate J, et al. Quality specifications for B-type natriuretic peptide assays. Clin Chem 2005;51:486-493
15. Alehagen U, Janzon M. A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting. Eur Heart J Fail 2008;10:260-266
16. Lewandroski-Lee E, Januzzi JL, Green SM, Tannous B, Wu AH, Smith A, et al. Multi-center validation of the response biomedical corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay. Clin Chim Acta 2007;386:20-24
17. Peetz D, Schweigert R, Jachmann N, Post F, Schinzel H, Lackner K. Method comparison of cardiac markers assays on Pathfast, Stratus CS, AxSYM, Immulite 2000, Triage, Elecsys and Cardiac Reader. Clin Lab 2006;52:605-614